Clinical Trial Update: Safety and Efficacy of a Single Subretinal Injection of JWK006 Gene Therapy in Subjects With Stargardt Disease(STGD1) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating safety and efficacy of a single subretinal injection of JWK006 gene therapy for Stargardt Disease (STGD1) is currently act…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stargardt Disease
• Stargardt Disease 1

Drugs mentioned

• JWK006 (JWK006)

Snippet

Sponsor: West China Hospital | Conditions: Stargardt Disease 1 | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING